Virtual Diagnostics provides emergency care and foundations for patients with chronic conditions and other high-risk patients who need frequent examinations of medical consultation. Virtual Diagnostics allows patients to communicate with doctors whenever they need them. Health systems and consumer-facing healthcare providers see point-of-care testing and digital diagnostic services as the next enhancement to the virtual care platform. Through this, patients could see a doctor online for a nagging health issue, and provide labs and tests done from home, holds promise to ease traffic bottlenecks at doctor’s offices, and improve patient engagement and satisfaction with telehealth.
Global Virtual Diagnostics Market estimated to grow with a significant rate during the forecast period, 2020-2027. The increasing awareness for early disease diagnosis and increasing demand for accessible and affordable diagnostics are vital factors expected to drive the global virtual diagnostics market in the future timeframe. Moreover, the growing number of diabetic patients around the world, coupled with an increasing preference for self-diagnosis and technological advancements in the diagnostic technology, will boost the global virtual diagnostics market in the upcoming periods. Additionally, the rise in geriatric population across the world and the subsequent growth in the prevalence of chronic and infectious diseases worldwide will augment the global virtual diagnostics industry in the expected periods.
The development of pathological AI to assist diagnosis will effectively reduce the workload of pathologists. Furthermore, increasing the adoption of fully automated instruments in diagnostic laboratories, which are more scalable, high-performance, help in decreasing hands-on time, and eliminate batch testing will expand the demand for virtual diagnostics in the near future. Digital pathological images can observe the tissue and cell morphology. Further, the rise in demand for virtual diagnostics for reducing by 20X the false positive rate in detection, which projected to accelerate the global virtual diagnostics market size in the estimated periods.
According to the United Nations, there are 703 million people aged 65 or older, a number that is projected to reach 1.5 billion by 2050. According to the latest population estimates and projections from UN DESA’s Population Division, 1 in 6 people in the world will be over the age of 65 by 2050, up from 1 in 11 in 2019. The latest projections also show that the number of people aged 80 or over will triple in the next 30 years.
Patients come to the emergency department, and nurses can get their vital signs, basic medical history, and physical examination data into the model. AI is allowing algorithms to generate predictive diagnoses to help physicians select which patients to prioritize. AI helps physicians decide which patients to prioritize and help physicians diagnose complex or rare diseases.
AI diagnosis technology can greatly reduce the workload of doctors and image data processing, and interpretation of results that need to be overcome.
Based on the type of diagnosis, the global Virtual Diagnostics market classified into Gastrointestinal Virtual Diagnostics, Ophthalmology Virtual Diagnostics, Cardiology Virtual Diagnostics, Pathology Virtual Diagnostics, and Others. The Cardiology Virtual Diagnostics segment projected to dominate the market by 2027, owing to the growing demand for the Virtual Diagnostics for remote monitoring to detect rhythm disturbances and blood glucose levels. It helps patient electronic medical records containing laboratory test results, physician’s notes, and other information on the disease, treatment, and epidemiology.
Pathology Virtual Diagnostics will be the fastest-growing segment by 2027, as it provides real-time guidance on risk, clinical care options, and outcomes. It also helps in blood test analysis.
Based on end-user, the global Virtual Diagnostics market categorized into Hospitals, Clinics, Ambulatory Surgical Centers, and Others. Hospitals segment expected to gain maximum revenue by 2027 on account of the large volume of diagnostic tests carried out in hospitals coupled with rising demand for rapid tests among patients.
Clinics segment will boom by the application of virtual diagnostics, which are capable of identifying all patients’ problems with the help of AI and machine learning.
Based on geography, the global Virtual Diagnostics market size segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. North America estimated to occupy the lion’s market share by 2027, owing to the high adoption of new technology in healthcare systems in the region coupled with the local presence of major players in the virtual diagnostics industry.
The Asia Pacific will drive by the increasing incidence of chronic diseases, rising healthcare spending by developing countries, and healthcare by the government’s reforms for infrastructural development.
Companies such as AliveCor Inc., Cardiologs Technologies, CapsoVision, Inc, Eyenuk, Inc, Healthy.io Ltd., hearX IP (Pty) Ltd, Hill-Rom Holdings, Inc., IDx Technologies Inc., Medtronic Plc., Monitored Therapeutics Inc., Olympus Corporation, Phelcom Technologies, and ResApp Health Limited are the key players in the Global Virtual Diagnostics Market.
|Market size value in 2020||USD 525 million|
|Revenue forecast in 2027||USD 1120 million|
|Growth Rate||CAGR of 14.78% from 2020 to 2027|
|Forecast period||2021 – 2027|
|Region covered||North America, Europe, Asia-Pacific, South America, and Middle East & Africa|
|Key companies Profiled||AliveCor Inc., Eyenuk, Inc, Healthy.io Ltd., Cardiologs Technologies, CapsoVision,
Inc, hearX IP (Pty) Ltd, ResApp Health Limited, Olympus Corporation,
Phelcom Technologies, Hill-Rom Holdings, Inc., IDx Technologies Inc.,
Medtronic Plc., and Monitored Therapeutics Inc.
By Type of Diagnosis
The growth rate of the Global Virtual Diagnostics Market is 14.78% from 2021 to 2027.
The size of the Global Virtual Diagnostics Market is USD 525 million in 2020, which will reach USD 1120 million by 2027.
An increase in the geriatric population and increasing demand for accessible and affordable diagnostics are the growth drivers of the Global Virtual Diagnostics Market.
Hospitals, Clinics, Ambulatory Surgical Centers are the end-users of the Virtual Diagnostics Market products.
AliveCor Inc., Eyenuk, Inc, Healthy.io Ltd., Cardiologs Technologies, CapsoVision, Inc, hearX IP (Pty) Ltd, ResApp Health Limited, Olympus Corporation, Phelcom Technologies, Hill-Rom Holdings, Inc., IDx Technologies Inc., Medtronic Plc., and Monitored Therapeutics Inc. are the key players in the Global Virtual Diagnostics Market.